Dr. Mark Higgins, MD

NPI: 1134193469
Total Payments
$114,634
2024 Payments
$6,034
Companies
71
Transactions
1,908
Medicare Patients
1,851
Medicare Billing
$237,003

Payment Breakdown by Category

Other$59,693 (52.1%)
Food & Beverage$38,440 (33.5%)
Travel$8,680 (7.6%)
Consulting$7,310 (6.4%)
Education$511.30 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $55,693 33 48.6%
Food and Beverage $38,440 1,841 33.5%
Travel and Lodging $8,680 21 7.6%
Consulting Fee $7,310 2 6.4%
Honoraria $4,000 2 3.5%
Education $511.30 9 0.4%

Top Paying Companies

Company Total Records Latest Year
Gilead Sciences, Inc. $67,253 282 $0 (2024)
ViiV Healthcare Company $14,007 310 $0 (2024)
Napo Pharmaceuticals Inc $5,393 33 $0 (2024)
Theratechnologies Inc. $2,769 35 $0 (2024)
Janssen Products, LP $2,365 9 $0 (2021)
ABBVIE INC. $2,354 136 $0 (2024)
EMD Serono, Inc. $2,284 132 $0 (2024)
Merck Sharp & Dohme LLC $1,801 99 $0 (2024)
AstraZeneca Pharmaceuticals LP $1,601 74 $0 (2024)
Lilly USA, LLC $1,400 74 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $6,034 257 ViiV Healthcare Company ($1,710)
2023 $4,495 212 ViiV Healthcare Company ($967.86)
2022 $13,011 189 Gilead Sciences, Inc. ($5,361)
2021 $10,610 161 Gilead Sciences, Inc. ($5,188)
2020 $7,085 190 Gilead Sciences, Inc. ($3,903)
2019 $29,909 300 Gilead Sciences, Inc. ($25,585)
2018 $24,400 309 Gilead Sciences, Inc. ($17,932)
2017 $19,090 290 Gilead Sciences Inc ($8,430)

All Payment Transactions

1,908 individual payment records from CMS Open Payments — Page 1 of 77

Date Company Product Nature Form Amount Type
12/26/2024 ViiV Healthcare Company RUKOBIA (Drug) Food and Beverage In-kind items and services $29.63 General
Category: HIV
12/20/2024 ViiV Healthcare Company APRETUDE (Biological) Food and Beverage In-kind items and services $9.22 General
Category: HIV
12/20/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $9.08 General
12/19/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $25.35 General
Category: Diabetes
12/19/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $9.00 General
12/19/2024 Theratechnologies Inc. EGRIFTA (Drug), TROGARZO Food and Beverage In-kind items and services $8.66 General
Category: HIV
12/18/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $31.77 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/18/2024 Theratechnologies Inc. EGRIFTA (Drug), TROGARZO Food and Beverage In-kind items and services $4.90 General
Category: HIV
12/12/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $26.78 General
Category: TESTOSTERONE REPLACEMENT THERAPY
12/12/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $6.68 General
Category: PAIN
12/11/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $28.72 General
12/10/2024 Napo Pharmaceuticals Inc Mytesi (Drug) Food and Beverage Cash or cash equivalent $24.63 General
Category: Infectious Disease
12/10/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $18.82 General
12/04/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $33.72 General
Category: PSYCHIATRY
12/04/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $31.52 General
Category: Oncology
12/04/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $7.44 General
Category: Diabetes
12/03/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $34.28 General
12/03/2024 ViiV Healthcare Company CABENUVA (Biological) Food and Beverage In-kind items and services $10.50 General
Category: HIV
11/28/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $6.69 General
Category: Diabetes
11/27/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $10.25 General
11/26/2024 Merck Sharp & Dohme LLC PIFELTRO (Drug), DELSTRIGO Food and Beverage In-kind items and services $28.77 General
Category: INFECTIOUS DISEASE
11/26/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $6.34 General
11/22/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $26.16 General
Category: PAIN
11/22/2024 ViiV Healthcare Company DOVATO (Drug) Food and Beverage In-kind items and services $7.41 General
Category: HIV
11/21/2024 ABBVIE INC. VIBERZI (Drug), CREON Food and Beverage In-kind items and services $16.19 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 601 841 $227,998 $74,790
2022 9 533 822 $175,603 $69,425
2021 8 399 559 $102,255 $53,130
2020 8 318 495 $86,495 $39,658
Total Patients
1,851
Total Services
2,717
Medicare Billing
$237,003
Procedure Codes
36

All Medicare Procedures & Services

36 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 208 371 $107,854 $34,562 32.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 143 197 $42,712 $12,267 28.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 58 73 $32,573 $9,430 29.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 43 43 $13,542 $5,984 44.2%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 13 13 $7,505 $3,673 48.9%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 37 37 $8,173 $2,799 34.3%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 12 12 $4,871 $2,116 43.4%
G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow Office 2023 13 21 $5,260 $1,840 35.0%
G0008 Administration of influenza virus vaccine Office 2023 45 45 $4,009 $1,486 37.1%
G0009 Administration of pneumococcal vaccine Office 2023 13 13 $864.45 $429.39 49.7%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 16 16 $634.64 $202.08 31.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 178 358 $87,641 $31,678 36.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 135 224 $42,112 $13,844 32.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 44 59 $23,989 $7,426 31.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 37 37 $7,956 $5,320 66.9%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2022 19 19 $5,795 $5,300 91.5%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2022 37 37 $2,706 $2,595 95.9%
G0008 Administration of influenza virus vaccine Office 2022 44 45 $2,225 $1,516 68.1%
G0009 Administration of pneumococcal vaccine Office 2022 28 28 $1,298 $949.49 73.2%
17000 Destruction of precancer skin growth, 1 growth Office 2022 11 15 $1,881 $795.73 42.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 144 251 $53,206 $25,749 48.4%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 50 70 $19,349 $10,066 52.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 82 115 $16,688 $7,787 46.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 31 31 $6,472 $4,860 75.1%
90694 Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage Office 2021 28 28 $1,988 $1,860 93.6%

About Dr. Mark Higgins, MD

Dr. Mark Higgins, MD is a Internal Medicine healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134193469.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Higgins, MD has received a total of $114,634 in payments from pharmaceutical and medical device companies, with $6,034 received in 2024. These payments were reported across 1,908 transactions from 71 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($55,693).

As a Medicare-enrolled provider, Higgins has provided services to 1,851 Medicare beneficiaries, totaling 2,717 services with total Medicare billing of $237,003. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location San Francisco, CA
  • Active Since 02/14/2006
  • Last Updated 12/04/2025
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1134193469

Products in Payments

  • Biktarvy (Drug) $12,235
  • Truvada (Drug) $10,761
  • Descovy (Drug) $7,429
  • Mytesi (Drug) $5,393
  • DOVATO (Drug) $5,000
  • Genvoya (Drug) $3,669
  • EGRIFTA (Drug) $2,641
  • PREZCOBIX (Drug) $1,099
  • APRETUDE (Biological) $1,057
  • TRIUMEQ (Drug) $1,049
  • VRAYLAR (Drug) $917.92
  • CABENUVA (Biological) $862.28
  • XIFAXAN (Drug) $816.51
  • Ozempic (Drug) $725.98
  • FARXIGA (Drug) $628.87
  • SYMTUZA (Drug) $607.31
  • JULUCA (Drug) $587.64
  • TRULICITY (Drug) $568.05
  • RUKOBIA (Drug) $547.66
  • Vascepa (Drug) $514.70

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in San Francisco